Interferon-β-1a induces increases in vascular cell adhesion molecule: Implications for its mode of action in multiple sclerosis

Journal of Neuroimmunology

Volumn 161, Issue 1-2, 2005, Pages 169-176

  Graber, J ^a   Zhan, M ^a   Ford, D ^a   Kursch, F ^a   Francis, G ^b   Bever, C ^a,c   Panitch, H ^d   Calabresi, P A ^a   Dhib Jalbut, S ^a,c,e,f  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b Serono Inc   (United States)

^c BALTIMORE VA MEDICAL CENTER   (United States)

^d UNIVERSITY OF VERMONT   (United States)

^e RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^f Robert Wood Johnson Medical School ^*  (United States)

Author keywords

Interferon beta (IFN 1a); Multiple sclerosis; Vascular cell adhesion molecule (VCAM); Very late antigen 4 (VLA 4)

Indexed keywords

BETA1A INTERFERON; GADOLINIUM; VASCULAR CELL ADHESION MOLECULE 1; VERY LATE ACTIVATION ANTIGEN 4;

ARTICLE; BLOOD BRAIN BARRIER; CELL ADHESION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; INTERMETHOD COMPARISON; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN INDUCTION; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE;

EID: 14844297366     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2004.11.017     Document Type: Article

References (47)

1. A. Bertoletto, A. Sala, S. Malucchi, F. Marnetto, M. Caldano, A. Di Sapio, M. Capobianco, and F. Gilli Biological activity of interferon betas in patients with multiple sclerosis is affected by treatment regimen and neutralising antibodies J. Neurol. Neurosurg. Psychiatry 75 2004 1294 1299
2. M.P. Bevilacqua Endothelial-leukocyte adhesion molecules Annu. Rev. Immunol. 1 1993 767 804
3. P.A. Brex, O. Ciccarelli, J.I. O'Riordan, M. Sailer, A.J. Thompson, and D.H. Miller A longitudinal study of abnormalities on MRI and disability from multiple sclerosis N. Engl. J. Med. 346 2002 158 164
4. P.A. Calabresi, L.R. Tranquill, J.M. Dambrosia, L.A. Stone, H. Maloni, C.N. Bash, J.A. Frank, and H.F. McFarland Increases in sVCAM-1 correlate with a decrease in MRI lesions in multiple sclerosis treated with interferon-beta-1b Ann. Neurol. 41 1997 669 674
5. P.A. Calabresi, C.M. Pelfrey, L.R. Tranquill, H. Maloni, and H.F. McFarland VLA-4 expression on peripheral blood lymphocytes is downregulated after treatment of multiple sclerosis with interferon beta Neurology 49 1997 1111 1116
6. P.A. Calabresi, A. Prat, K. Biernacki, J. Rollins, and J.P. Antel T lymphocytes conditioned with interferon β induce membrane and soluble VCAM on human brain endothelial cells J. Neuroimmunol. 115 2001 161 167
7. T.M. Carlos, B.R. Schwartz, N.L. Kovach, E. Yee, M. Rosa, L. Osborn, G. Chi-Rosso, B. Newman, R. Lobb, and M. Rosso Vascular cell adhesion molecule-1 mediates lymphocyte adherence to cytokine-activated cultured human endothelial cells Blood 76 1990 965 970
8. R.A. Carter, I.K. Campbell, K. O'Donnell, and I.P. Wicks Vascular cell adhesion molecule-1 (VCAM-1) blockade in collagen-induced arthritis reduces joint involvement and alters B cell trafficking Clin. Exp. Immunol. 128 2002 44 51
9. J.R. Chan, S.H. Hyduk, and M.I. Cybulsky α4β1-integrin/VCAM-1 interaction activates αLβ2-integrin-mediated adhesion to ICAM-1 in human T cells J. Immunol. 164 2000 746 753
10. C. Chen, J.L. Mobley, O. Dwir, F. Shimron, V. Grabovsky, R.R. Lobb, Y. Shimizu, and R. Alon High affinity Very Late Antigen-4 subsets expressed on T cells are mandatory for spontaneous adhesion strengthening but not for rolling on VCAM-1 in shear flow J. Immunol. 162 1999 1084 1095
11. A. Compston, and A. Coles Multiple sclerosis Lancet 359 2002 1221 1231
12. F. Deisenhammer, I. Mayringer, J. Harvey, E. Dilitz, T. Gasse, D. Stadlbauer, M. Reindl, and T. Berger A comparative study of the relative bioavailability of different interferon beta preparations Neurology 54 2000 2055 2060
13. S. Dhib-Jalbut, H. Jiang, and G.J. Williams The effect of interferon-β-1b on lymphocycte-endothelial cell adhesion J. Neuroimmunol. 1996 215 222
14. A.G. Droogan, A.D. Crockard, S.A. McMillan, and S.A. Hawkins Effects of intravenous methylprednisolone therapy on leukocyte and soluble adhesion molecule expression in MS Neurology 50 1998 224 230
15. L. Durelli Is multiple sclerosis a disease that requires frequent beta interferon dosing? J. Neurol. 252 S4 2004 SIV/13 SIV/24
16. L. Durelli, E. Verdun, P. Barbero, M. Bergui, E. Versino, A. Ghezzi, E. Montanari, M. Zaffaroni Independent Comparison of Interferon (INCOMIN) trial study group Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomized multicentre study (INCOMIN) The Lancet 359 2002 1453 1460
17. R. Fassler, E. Georges-Labouesse, and E. Hirsch Genetic analysis of integrin function in mice Curr. Opin. Cell Biol. 8 1996 641 646
18. G. Giovannoni, M. Lai, J. Thorpe, D. Kidd, V. Chamoun, A.J. Thompson, D.H. Miller, M. Feldmann, and E.J. Thompson Longitudinal study of soluble adhesion molecules in multiple sclerosis: correlation with gadolinium-enhanced magnetic resonance imaging Neurology 48 1997 1557 1565
19. Interferon Beta Multiple Sclerosis Study Group Interferon-β-1b is effective in relapsing-remitting multiple sclerosis: I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial Neurology 43 1993 655 661
20. International Natalizumab Multiple Sclerosis Trial Group A controlled trial of natalizumab for relapsing multiple sclerosis N. Eng. J. Med. 348 2003 15 23
21. S.J. Kent, S.J. Karlik, G.P. Rice, and H.C. Horner A monoclonal antibody to α4-integrin reverses the MRI detectable signs of experimental allergic encephalomyelitis in the guinea pig Proc. Int. Soc. Magn. Reson. Imaging 3 1994 1400
22. S.J. Kent, S.J. Karlik, C. Cannon, D.K. Hines, T.A. Yednock, L.C. Fritz, and H.C. Horner A monoclonal antibody to α4-integrin suppresses and reverses active experimental allergic encephalomyelitis J. Neuroimmunol. 58 1995 1 10
23. J. Kraus, B. Engelhardt, N. Chatzimanolis, R. Bauer, J. Tofighi, B.S. Kuehne, C. Laske, E. Stolz, P. Frielinghaus, C. Schaefer, F. Blaes, H. Traupe, M. Kaps, and P. Oschmann Cell surface bound and soluble adhesion molecules in CSF and blood in MS: correlation with MRI-measures of subclinical disease severity and activity J. Neuroimmunol. 122 2002 175 185
24. P.F. Lalor, J.M. Clements, R. Pigott, M.J. Humphries, J.H. Spragg, and G.B. Nash Association between receptor density, cellular activation, and transformation of adhesive behavior of flowing lymphocytes binding to VCAM-1 Eur. J. Immunol. 27 1997 1422 1429
25. A. Lechleitner, J. Fille, D.R. Johnson, and P. Petzelbauer Interferon enhances Tumor Necrosis Factor-induced Vascular Cell Adhesion Molecule (CD106) expression in human endothelial cells by an Interferon-Related-Factor-1- dependent pathway J. Exp. Med. 187 1998 2023 2030
26. Y.W. Lee, H. Kuhn, B. Hennig, A.S. Neish, and M. Toborek IL-4-Induced oxiadative stress upregulates VCAM-1 gene expression in human endothelial cells J. Mol. Cell. Cardiol. 33 2001 83 94
27. V.I. Leussink, U.K. Zettl, S. Jander, R.B. Pepinsky, R.R. Lobb, G. Stoll, K.V. Toyka, and R. Gold Blockade of signaling via the Very Late Antigen (VLA-4) and its counterligand vascular cell adhesion molecule-1 (VCAM-1) causes increased T cell apoptosis in experimental autoimmune neuritis Acta Neuropathol. 103 2002 131 136
28. D.K.B. Li, G.J. Zhao, D.W. Paty University of British Columbia MS/MRI Analysis Research Group SPECTRIMS Study Group Randomized controlled trial of interferon-beta-1a in secondary progressive MS: MRI results Neurology 56 2001 1505 1513
29. -(Naïve) T cells roll efficiently on E- and P-Selectin and Vascular Cell Adhesion Molecule-1 under flow J. Immunol. 158 1997 3640 3650
30. R.R. Lobb, and L. Osborne VCAM-1 T. Kreis R. Vale Guidebook to the extracellular matrix, anchor and adhesion proteins 2nd ed. 1999 Oxford Univ. Press
31. A. Miller, N. Lanir, S. Shapiro, M. Revel, S. Honigman, A. Kinarty, and N. Lahat Immunoregulatory effects of interferon-beta and interacting cytokines on human vascular endothelial cells: implications for multiple sclerosis and other autoimmune diseases J. Neuroimmunol. 64 1996 151 161
32. R. Mossner, K. Fassbender, J. Kuhnen, A. Schwartz, and M. Hennerici Vascular cell adhesion molecule-a new approach to detect endothelial cell activation in MS and encephalitis in vivo Acta Neurol. Scand. 93 1996 118 122
33. H. Panitch, D.S. Goodin, G. Francis, P. Chang, P.K. Coyle, P. O'Connor, E. Monaghan, D. Li, B. Weinshenker EVIDENCE Study Group Evidence of Interferon Dose-response: European North American Comparative Efficacy. University of British Columbia MS/MRI Research Group. Randomized comparative study of interferon beta-1a treatment regimens in MS: the EVIDENCE trial Neurology 59 2002 1507 1517
34. D.W. Paty, D.K. Li Interferon Beta Multiple Sclerosis Study Group Interferon-β-1b is effective in relapsing-remitting multiple sclerosis: I. MRI analysis of a multicenter, randomized, double-blind, placebo-controlled trial Neurology 43 1993 662 667
35. J.W. Peterson, L. Bo, S. Mork, A. Chang, R.M. Ransohoff, and B.D. Trapp VCAM-1-positive microglia target oligodendrocytes at the border of multiple sclerosis lesions J. Neuropath. Exp. Neurol. 61 2002 539 546
36. J.W. Pierce, R. Schoenleber, G. Jesmok, J. Best, S.A. Moore, T. Collins, and M.E. Gerritsen Novel inhibitors of cytokine-induced Iκ-βα phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo J. Biol. Chem. 272 1997 21096 21103
37. C.M. Poser, D.W. Paty, L. Scheinberg, W.I. McDonald, F.A. Davis, G.C. Ebers, K.P. Johnson, W.A. Sibley, D.H. Silberberg, and W.W. Tourtellotte New diagnostic criteria for multiple sclerosis: guidelines for research protocols Ann. Neurol. 13 1983 227 231
38. G.P. Rice, B. Incorvaia, L. Munari, G. Ebers, C. Polman, R. D'Amico, and G. Filippini Interferon in relapsing-remitting multiple sclerosis Cochrane Database Syst. Rev. 4 2001 CD002002
39. L.E. Rothuizen, T. Buclin, F. Spertini, I. Trinchard, A. Munafo, P.A. Buchwalder, A. Ythier, and J. Biollaz Influence of interferon-beta-1a dose frequency on PBMC cytokine secretion and biological effect markers J. Neuroimmunol. 99 1999 131 141
40. M. Soilu-Hanninen, A. Salmi, and R. Salonen Interferon-beta downregulates expression of VLA-4 antigen and antagonizes interferon-gamma induced expression of HLA-DQ on human peripheral blood monocytes J. Neuroimmunol. 60 1995 99 106
41. S. Sturzbecher, R. Maibauer, A. Heuner, K. Beckmann, and B. Aufdembrinke Pharmacodynamic comparison of single doses of IFN-β-1a and IFN-β-1b in healthy volunteers J. Interferon Cytokine Res. 19 1999 1257 1264
42. O. Stuve, N.P. Dooley, J.H. Uhm, J.P. Antel, G.S. Francis, G. Williams, and V.W. Yong Interferon β-1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9 Ann. Neurol. 40 1996 853 863
43. A. Svenningsson, G.K. Hansson, O. Andersen, R. Andersson, M. Patarroyo, and S. Stemme Adhesion molecule expression on cerebrospinal fluid T lymphocytes: evidence for common recruitment mechanism in multiple sclerosis, aseptic meningitis and normal controls Ann. Neurol. 34 1993 155 161
44. C. Weber, and T.A. Springer Interaction of Very Late Antigen-4 with VCAM-1 supports transendothelial chemotaxis of monocytes by facilitating lateral migration J. Immunol. 161 1998 6825 6834
45. G.J. Willams, and P.L. Witt Comparative study of the pharmacodynamic and pharmacologic effects of betaseron and avonex J. Interferon Cytokine Res. 18 1998 967 975
46. D. Wong, R. Prameya, and K. Dorovini-Zis In vitro adhesion and migration of T lymphocytes across monolayers of human brain microvascular endothelial cells: regulation by ICAM-1, VCAM-1 E-Selectin and PECAM-1 J. Neuropathol. Exp. Neurol. 58 1999 138 152
47. T.A. Yednock, C. Cannon, L.C. Fritz, F. Sanchez-Madrid, L. Steinman, and N. Karin Prevention of experimental autoimmune encephalomyelitis by antibodies against α4β1-integrin Nature 356 1992 63 66